Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.62 |
| ▸ | PPARD | Q03181 | 12/20 | 0.58 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.51 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.51 |
| ▸ | HTR6 | P50406 | 1/20 | 0.49 |
| ▸ | PPARA | Q07869 | 4/20 | 0.47 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.46 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7845908 | 1.00 | FFAR1 (0.62) | FFAR1PPARDMTNR1AMTNR1BHTR6 | |
| SCHEMBL7847075 | 1.00 | FFAR1 (0.62) | FFAR1PPARDMTNR1AMTNR1BHTR6 | |
| SCHEMBL30301824 | 0.90 | FFAR1 (0.52) | FFAR1PPARD | |
| SCHEMBL3590904 | 0.90 | FFAR1 (0.52) | FFAR1PPARD | |
| SCHEMBL3246802 | 0.88 | FFAR1 (0.51) | FFAR1PPARD | |
| SCHEMBL11732903 | 0.86 | MTNR1A (0.49) | FFAR1PPARDMTNR1AMTNR1BHTR6 | |
| SCHEMBL1567606 | 0.86 | MTNR1A (0.51) | FFAR1PPARDMTNR1AMTNR1BHTR6 | |
| SCHEMBL7296740 | 0.84 | MTNR1A (0.50) | FFAR1PPARDMTNR1AMTNR1BHTR6 | |
| SCHEMBL14356155 | 0.84 | MTNR1B (0.50) | FFAR1PPARDMTNR1AMTNR1BHTR6 | |
| SCHEMBL4714587 | 0.84 | HTR6 (0.51) | FFAR1PPARDMTNR1AMTNR1BHTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230364244-A1 | DENDRIMER COMPOSITIONS AND METHODS FOR DRUG DELIVERY TO INJURED KIDNEY | Ashvattha Therapeutics, Inc. (US) | 2023-11-16 | — | — | US | claimed |
| CN-116249558-A | Dendrimer compositions and methods for drug delivery to injured kidneys | 阿什瓦塔治疗股份有限公司 | 2023-06-09 | — | — | CN | claimed |
| EP-4181913-A1 | DENDRIMER COMPOSITIONS AND METHODS FOR DRUG DELIVERY TO INJURED KIDNEY | Ashvattha Therapeutics, Inc. (US) | 2023-05-24 | — | — | EP | claimed |
| US-5929078-A | ANTISEROTONINE AGENT | SYNTHELABO (FR) | 1999-07-27 | — | — | US | claimed |
| JP-5085999-A | — | — | None | — | — | JP | disclosed |
| CN-119923389-A | 2-Substituted piperidine derivative, preparation method and medical application thereof | 江苏豪森药业集团有限公司 | 2025-05-02 | — | — | CN | disclosed |
| CN-119219639-A | Fused polycyclic compounds, process for their preparation and their pharmaceutical use | 江苏豪森药业集团有限公司 | 2024-12-31 | — | — | CN | disclosed |
| CN-119156393-A | Cyclic compound, preparation method and medical application thereof | 翰森生物有限责任公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-118900917-A | Bicyclic heterocycles and ligands thereof for targeted delivery of therapeutic agents | 翰森生物有限责任公司 | 2024-11-05 | — | — | CN | disclosed |
| CN-118696037-A | Azacyclic amide derivatives, preparation method and medical application thereof | 翰森生物有限责任公司 | 2024-09-24 | — | — | CN | disclosed |
| CN-118510765-A | Piperidinyl indole derivatives, preparation method and medical application thereof | 翰森生物有限责任公司 | 2024-08-16 | — | — | CN | disclosed |
| CN-115052596-B | ADAMTS inhibitor, preparation method and medical application thereof | 江苏恒瑞医药股份有限公司 | 2024-06-14 | — | — | CN | disclosed |
| EP-0395199-A1 | Substituted tetrahydroindane derivatives and their use as intermediates | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1990-10-31 | — | — | EP | disclosed |
| EP-0372484-A2 | Condensed benzene derivative | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1990-06-13 | — | — | EP | disclosed |
| US-4933319-A | Substituted tetrahydroindane derivatives and organoleptic uses of substituted tetrahydroindanes | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1990-06-12 | — | — | US | disclosed |
| US-4902840-A | Substituted tetrahydroindane derivatives and organoleptic uses of substituted tetrahydroindanes | INTERNATIONAL FLAVORS AND FRAGRANCES INC. (US) | 1990-02-20 | — | — | US | disclosed |
| US-4152527-A | 15-Substituted-ω-pentanorprostaglandins | PFIZER INC. (US) | 1979-05-01 | — | — | US | disclosed |
| US-4127578-A | Diene intermediates for indantetrols | E. R. SQUIBB & SONS, INC. (US) | 1978-11-28 | — | — | US | disclosed |
| US-4092318-A | HYPOTENSIVES | E. R. SQUIBB & SONS, INC. (US) | 1978-05-30 | — | — | US | disclosed |
| US-4044040-A | HYPERTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1977-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230364244-A1 | DENDRIMER COMPOSITIONS AND METHODS FOR DRUG DELIVERY TO INJURED KIDNEY | PPARA, PPARD, PPARG | FFAR1 97/4885PPARD 2/4885MTNR1A 53/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.